Can Tiger Milk Mushroom Treat Breast Hyperplasia? New Clinical Patent News
Beyond Respiratory Health: Is Tiger Milk Mushroom the New Frontier for Treating Nodules?
If you have been searching for “Natural ways to manage breast hyperplasia” or wondering “Can medicinal mushrooms help dissolve nodules?”, you are tapping into one of the most exciting shifts in modern Traditional Chinese Medicine (TCM).
While many know Tiger Milk Mushroom (Lignosus rhinocerus) for its lung-cleansing properties, a groundbreaking new medical partnership in Hainan is proving it can do much more. Hainan Lishu Pharmacy has officially acquired a clinical patent from Chengmai County TCM Hospital that uses Tiger Milk Mushroom as the core ingredient to treat breast hyperplasia and other nodule-related conditions. The raw materials applied in this patented formula are sourced from under-forest cultivation bases located in Baisha County, Hainan.
Why This is a “Game Changer” for Quality and Trust
When looking for health supplements, most users ask: “Is this product scientifically proven, or just a folk remedy?” This new development moves Tiger Milk Mushroom firmly into the category of clinical-grade medicine.
From Wild Forests to Clinical Labs: This isn’t just about picking mushrooms. The project involves the Chinese Academy of Tropical Agricultural Sciences, which pioneered the domestication of the species, ensuring a stable and potent supply. The academy conserves specialized Hainan fungal strains and provides standardized cultivation technical guidance for local planting bases.
The Gold Standard of Purity: In September 2025, official Quality Standards for Tiger Milk Mushroom were released. This means the “raw agricultural product” has now graduated to a “qualified pharmaceutical ingredient,” meeting strict laboratory benchmarks for safety and efficacy. Issued by Hainan medical regulatory authorities, the standard specifies testing indicators including polysaccharide content, moisture and heavy metals for unified batch inspection.
Proven by Doctors, Not Just Data: Led by Vice President Wu Weiyan, the clinical team at Chengmai TCM Hospital developed this formula based on real patient feedback. It isn’t just a theory; it’s a patented treatment derived from frontline medical experience.
Common Questions: Understanding the Science Behind the Fungus
“How exactly does Tiger Milk Mushroom work for breast hyperplasia?”
Breast hyperplasia and nodules are often linked to inflammation and immune imbalances. Tiger Milk Mushroom is celebrated in the scientific community for its potent anti-inflammatory and immune-regulating properties. By targeting the underlying inflammatory pathways, this patented formula aims to provide a non-invasive, TCM-based solution for nodule management.
“Is Hainan Tiger Milk Mushroom different from others?”
Yes. Through the Hainan Free Trade Port’s supportive policies, a unique “Industry-University-Research” chain has been formed. This ensures that the mushroom is grown in its native tropical environment (under-forest economy) but processed using high-end pharmaceutical technology. Most Hainan batches are cultivated under rubber trees without excessive artificial additives, adapting to local tropical temperature and humidity all year round.
The Future: From Field to Pharmacy
For those asking, “When can I get Tiger Milk Mushroom medication for nodules?”, the wait is getting shorter. The transformation of this patent into hospital-made preparations and innovative new drugs is already underway. Hainan currently maintains large-scale under-forest planting areas to sustain raw material supply for subsequent pharmaceutical development.
This partnership represents the “missing link” in the industry: Clinical Technology. We are no longer just selling a raw ingredient; we are delivering a medically validated solution for patients seeking safe, effective, and accessible TCM treatments for nodules.
[Good News] Hainan Lishu Pharmaceutical has acquired a patent from Chengmai County Traditional Chinese Medicine Hospital for a traditional Chinese medicine formula centered on Ganoderma lucidum var. hulu, used to treat nodular conditions such as breast hyperplasia, thereby filling a critical gap in “clinical technology” for the entire industry
[Good News] Hainan Lishu Pharmaceutical has acquired a patent from Chengmai County Traditional Chinese Medicine Hospital for a traditional Chinese medicine formulation centered on tiger milk mushroom, intended for the treatment of nodular conditions such as breast hyperplasia, thereby filling a critical gap in “clinical technology” across the entire industry
Good News
Recently, Chengmai County Traditional Chinese Medicine Hospital successfully transferred a patent to our company (Hainan Lishu Pharmaceutical Co., Ltd.). This patent centers on a formula featuring the tiger milk mushroom—a distinctive edible and medicinal fungus native to Hainan—and is primarily intended for the TCM treatment of nodular diseases such as breast hyperplasia. Building on this patent, both parties will collaborate to develop in-house TCM formulations and innovative drugs.
This collaboration has received significant attention from Hainan’s official media. It marks our company’s official entry into the development of hospital-prepared TCM formulations and innovative drugs, and serves as a vivid example of implementing the “Hainan Province Three-Year Action Plan for Accelerating the High-Quality Development of the Traditional Chinese Medicine Industry (2026–2028),” specifically the provisions on “promoting the innovation and transformation of medical institution formulations” and “accelerating the conversion of scientific and technological achievements into real productive capacity.”
01
From Understory Cultivation to Clinical Validation: A Complete Innovation Chain
Many are curious as to why a collaboration between a county-level hospital and our company could result in patent commercialization and coverage by Hainan’s official media. The answer lies in an integrated “industry-academia-research-application” chain spanning the entire value chain.
Source Domestication: The team led by Xu Lin at the Institute of Environment and Plant Protection, Chinese Academy of Tropical Agricultural Sciences, was the first to successfully domesticate the tiger milk mushroom from the wild and promoted its large-scale under-forest cultivation in Hainan. This provided our company with a stable and authentic raw material base.
Setting Standards First: In September 2025, the “Quality Standards for Tiger Milk Mushroom Herbal Materials and Slices,” led by Researcher Liu Yangyang’s team at the Hainan Branch of the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, was officially released, filling a gap in this field domestically. The introduction of these standards elevated the tiger milk mushroom from an “agricultural product” to a “qualified herbal medicine.”
Clinical Refinement: The “Innovation Studio” led by Wu Weiyan, Deputy Director of Chengmai County Traditional Chinese Medicine Hospital, leveraged clinical feedback from patients with nodular diseases to continuously optimize formulations centered on the tiger milk mushroom. This ultimately resulted in a set of data-backed, clinically effective patented traditional Chinese medicine formulas.
2. The Innovative Power of Healthcare
As a county-level Grade II hospital, Chengmai County Traditional Chinese Medicine Hospital’s ability to forge such a path of scientific and technological innovation is inseparable from its clear positioning.
It is precisely this commitment to staying “grounded” that enabled Wu Weiyan’s team to secure funding for Hainan Province’s first batch of “South China Sea Rising Stars” projects and the Hainan Provincial Health and Wellness Science and Technology Innovation Joint Project, marking a breakthrough for grassroots hospitals across the province in securing provincial-level competitive research grants.
03
Filling a Critical Gap in the Industry: From Raw Materials to High-Value Innovative Medicines
For Lishu Group, the significance of this patent transfer extends far beyond simply acquiring an intellectual property right.
In the past, the company accumulated extensive experience in the cultivation and primary processing of tiger milk mushrooms; now, through deep collaboration with frontline clinical teams, we have filled the critical “clinical technology” gap in the industrial chain—transitioning from selling raw materials to truly advancing toward the pinnacle of “innovative traditional Chinese medicines.”
A company representative stated: “ “The coverage by Hainan’s official media is a tremendous encouragement for our industry-academia-research approach. Clinicians understand patient needs best, while enterprises understand industrialization pathways best. We will use this as an opportunity to accelerate in-depth cooperation with institutions such as Chengmai County Hospital of Traditional Chinese Medicine, the Tropical Agricultural Sciences Academy, and the Institute of Medicinal Plant Development, enabling Hainan tiger milk mushroom to move from the fields to a broader medical market and provide safe, effective, and accessible TCM solutions for patients with nodular diseases.”
Looking Ahead
Currently, the technology transfer of the acquired patent has entered the implementation phase—preparations for formulation development are proceeding at a rapid pace. We believe that, with the policy tailwind provided by the “Hainan Province Three-Year Action Plan for Accelerating the High-Quality Development of the Traditional Chinese Medicine Industry,” the attention from mainstream media such as “Hainan Official Media,” and the combined support of various scientific research forces, Lishu Group will forge a unique development path characterized by “distinctive southern Chinese medicinal herbs + clinical translation + industrial implementation.”
Let quality medicines come from Hainan, and let health benefit the public. Let’s look forward to the early launch of the tiger milk mushroom formulation!
